Sequencing-based surveillance is emerging as an effective way to identify new coronavirus strains and other unknown pathogens. As such, the introduction of COVID-19 vaccines by India has lowered the pressure on companies in the global NGS sample preparation market to detect mutations in the strain. Moreover, companies such as the U.S. biotechnology company Illumina continue to provide public health officials and researchers with valuable insight on tracking the transmission routes of the virus globally.
Companies in the NGS sample preparation market are increasing efforts to identify viral mutations that may affect vaccine potency. They are boosting R&D to create screen targets that hold promising potentials in COVID-19 therapeutics. Companies are identifying and characterizing antimicrobial resistance alleles and respiratory co-infections.
Next generation sequencing (NGS) is undergoing a significant change by evolving from a technology used for research purposes to the one that is applied in clinical diagnostics. However, companies are faced with drawbacks in library preparation and different automation strategies. It has been found that pipetting workstations facilitate high throughput processing, but offer limited flexibility during procedures. This has led to the emergence of microfluidic solutions that offer great potential due to miniaturization and decreased investment costs.
Microfluidic systems are being used for automation. However, microfluidic systems are relatively new and only a handful of them are being commercialized. Hence, companies in the NGS sample preparation market are partnering with academic groups to advance in the field of microfluidic systems and pipetting workstations to assess its implementation in library preparation protocols.
Automation in the NGS sample preparation market has led to stakeholders making use of robotic instruments to decrease cost and increase output in lab settings. Biocompare - a provider of life sciences products and new technologies, is keen on adding robotic instruments in their sequencing procedures to enable cost efficient automation of processes.
The NGS sample preparation market is expected to cross the revenue of US$ 4.1 Bn by 2030, as automation is gauging strong business grounds in reagent handling, right from isolation to library prep.
Apart from medical services, companies in the NGS sample preparation market are tapping into incremental opportunities in the fields of agriculture and animal research to broaden their revenue streams. This is evident since the market is predicted to expand at an astonishing CAGR of 16.2% during the assessment period.
NGS is revolutionizing agricultural productivity, and helping to evaluate its role in human health, gut, air, water, and soil microbiomes. Companies in the NGS sample preparation market are increasing their research in the discovery of new disease genes in animals pertaining to multigenic disorders. NGS is also helping to track the source of plant diseases and is suggesting ways to eliminate them.
The NGS-based metagenomic screening has sparked advancements in the field of veterinary medicines. However, there is a lack of protocols tailored to veterinary requirements, which is affecting the growth of the NGS sample preparation market. Hence, companies are developing NGS-based protocols that can be used in veterinary virology. Thus, companies are gaining a strong research ground in porcine samples that are spiked with different DNA and RNA viruses.
On the other hand, foodborne viral infections are emerging as a leading cause for increased morbidity and mortality worldwide. Hence, companies in the NGS sample preparation market are increasing their focus in viral partial genomic sequencing in order to track foodborne outbreaks. NGS is being used for the detection and characterization of the viral density in food.
Analysts’ Viewpoint
Apart from human health, companies in the NGS sample preparation market are gaining a strong research base in identifying how coronavirus strains have the potential to affect animal health. NGS is helping to track the source of plant diseases to avoid food wastage on the global level. However, viral partial genomic sequencing also provides a comprehensive description of the RNA and DNA virome, which causes foodborne viral infections. However, research in this field is found to be limited to electron microscopy, which lacks the sensitivity required for meaningful food testing. Hence, companies should combine the use of microfluidic devices with multiplexed polymerase chain reaction (PCR) to allow detection of different RNA foodborne viruses.
Global Tissue Processing Systems Market - Segmentation
|
Product Type |
|
| Application |
|
| End-user |
|
| Region |
|
NGS sample preparation market is expected to cross the revenue of US$ 4.1 Bn by 2030
NGS sample preparation market is projected to expand at a CAGR of ~16% from 2020 to 2030
NGS sample preparation market is driven by rapid expansion of the life sciences industry and rise in inclination toward personalized medicines
The drug and biomarker discovery segment accounted for a major share of the global NGS sample preparation market
Key players in the global NGS sample preparation market include QIAGEN, Thermo Fisher Scientific, Inc., Merck KGaA (Merck Millipore), Hoffmann-La Roche Ltd., Agilent Technologies
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global NGS Sample Preparation Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.3. Opportunities
4.4. Global NGS Sample Preparation Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events (Mergers, Acquisitions, Product Launches, Strategic Partnerships, etc.)
5.2. Technological Advancement
5.3. Regulatory Scenario
5.4. COVID-19 Impact Analysis
6. Global NGS Sample Preparation Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2018–2030
6.3.1. Instruments
6.3.2. Kits, Reagents, and Consumables
6.4. Market Attractiveness Analysis, by Product
7. Global NGS Sample Preparation Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2018–2030
7.3.1. Drug and Biomarker Discovery
7.3.2. Diagnostics
7.3.3. Precision Medicine
7.3.4. Others (agriculture and animal research)
7.4. Market Attractiveness Analysis, by Application
8. Global NGS Sample Preparation Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2018–2030
8.3.1. Hospitals & Clinical Diagnostic Centers
8.3.2. Biotechnology & Pharmaceutical Companies
8.3.3. Academic & Research Institutes
8.3.4. Others (CROs, CMOs etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global NGS Sample Preparation Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America NGS Sample Preparation Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast, by Product, 2018–2030
10.2.1. Instruments
10.2.2. Kits, Reagents & Consumables
10.3. Market Value Forecast, by Application, 2018–2030
10.3.1. Drug and Biomarker Discovery
10.3.2. Diagnostics
10.3.3. Precision Medicine
10.3.4. Others (agriculture and animal research)
10.4. Market Value Forecast, by End-user, 2018–2030
10.4.1. Hospitals & Clinical Diagnostic Centers
10.4.2. Biotechnology & Pharmaceutical Companies
10.4.3. Academic & Research Institutes
10.4.4. Others (CROs, CMOs etc.)
10.5. Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe NGS Sample Preparation Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2018–2030
11.2.1. Instruments
11.2.2. Kits, Reagents, and Consumables
11.3. Market Value Forecast by Application, 2018–2030
11.3.1. Drug and Biomarker Discovery
11.3.2. Diagnostics
11.3.3. Precision Medicine
11.3.4. Others (agriculture and animal research)
11.4. Market Value Forecast, by End-user, 2018–2030
11.4.1. Hospitals & Clinical Diagnostic Centers
11.4.2. Biotechnology & Pharmaceutical Companies
11.4.3. Academic & Research Institutes
11.4.4. Others (CROs, CMOs etc.)
11.5. Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe NGS Sample Preparation Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific NGS Sample Preparation Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2018–2030
12.2.1. Instruments
12.2.2. Kits, Reagents, and Consumables
12.3. Market Value Forecast, by Application, 2018–2030
12.3.1. Drug and Biomarker Discovery
12.3.2. Diagnostics
12.3.3. Precision Medicine
12.3.4. Others (agriculture and animal research)
12.4. Market Value Forecast, by End-user, 2018–2030
12.4.1. Hospitals & Clinical Diagnostic Centers
12.4.2. Biotechnology & Pharmaceutical Companies
12.4.3. Academic & Research Institutes
12.4.4. Others (CROs, CMOs etc.)
12.5. Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America NGS Sample Preparation Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2018–2030
13.2.1. Instruments
13.2.2. Kits, Reagents, and Consumables
13.3. Market Value Forecast, by Application, 2018–2030
13.3.1. Drug and Biomarker Discovery
13.3.2. Diagnostics
13.3.3. Precision Medicine
13.3.4. Others (agriculture and animal research)
13.4. Market Value Forecast, by End-user, 2018–2030
13.4.1. Hospitals & Clinical Diagnostic Centers
13.4.2. Biotechnology & Pharmaceutical Companies
13.4.3. Academic & Research Institutes
13.4.4. Others (CROs, CMOs etc.)
13.5. Market Value Forecast, by Country/Sub-region, 2018-2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa NGS Sample Preparation Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2018–2030
14.2.1. Instruments
14.2.2. Kits, Reagents, and Consumables
14.3. Market Value Forecast, by Application, 2018–2030
14.3.1. Drug and Biomarker Discovery
14.3.2. Diagnostics
14.3.3. Precision Medicine
14.3.4. Others (agriculture and animal research)
14.4. Market Value Forecast, by End-user, 2018–2030
14.4.1. Hospitals & Clinical Diagnostic Centers
14.4.2. Biotechnology & Pharmaceutical Companies
14.4.3. Academic & Research Institutes
14.4.4. Others (CROs, CMOs etc.)
14.5. Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Share Analysis, by Company, 2019
15.2. Company Profiles
15.2.1. QIAGEN
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Financial Overview
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Thermo Fisher Scientific, Inc.
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. Financial Overview
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. Merck KGaA (Merck Millipore)
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. Financial Overview
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. F. Hoffmann-La Roche Ltd.
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Agilent Technologies
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. Financial Overview
15.2.5.4. Strategic Overview
15.2.5.5. SWOT Analysis
15.2.6. Promega Corporation
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Illumina, Inc.
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. Financial Overview
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. Integrated DNA Technologies, Inc. (Danaher Corporation)
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. Financial Overview
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. New England Biolabs
15.2.9.1. Company Description
15.2.9.2. Business Overview
15.2.9.3. Financial Overview
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Tecan Trading AG
15.2.10.1. Company Description
15.2.10.2. Business Overview
15.2.10.3. Financial Overview
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis
List of Tables
Table 01: Global NGS Sample Preparation Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 02: Global NGS Sample Preparation Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 03: Global NGS Sample Preparation Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 04: Global NGS Sample Preparation Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 05: North America NGS Sample Preparation Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 06: North America NGS Sample Preparation Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 07: North America NGS Sample Preparation Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 08: North America NGS Sample Preparation Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 09: Europe NGS Sample Preparation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 10: Europe NGS Sample Preparation Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 11: Europe NGS Sample Preparation Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 12: Europe NGS Sample Preparation Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 13: Asia Pacific NGS Sample Preparation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
Table 14: Asia Pacific NGS Sample Preparation Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 15: Asia Pacific NGS Sample Preparation Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 16: Asia Pacific NGS Sample Preparation Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 17: Latin America NGS Sample Preparation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18: Latin America NGS Sample Preparation Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 19: Latin America NGS Sample Preparation Market Value (US$ Mn) Forecast, by Application, 2018-2030
Table 20: Latin America NGS Sample Preparation Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 21: Middle East & Africa NGS Sample Preparation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 22: Middle East & Africa NGS Sample Preparation Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 23: Middle East & Africa NGS Sample Preparation Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 24: Middle East & Africa NGS Sample Preparation Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global NGS Sample Preparation Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global NGS Sample Preparation Market Value Share, by Product, 2020
Figure 03: Global NGS Sample Preparation Market Value Share, by Application, 2020
Figure 04: Global NGS Sample Preparation Market Value Share, by End-user, 2020
Figure 05: Global NGS Sample Preparation Market Value Share, by Extraction Type, 2020
Figure 06: Global NGS Sample Preparation Market Value Share Analysis, by Product, 2020 and 2030
Figure 07: Global NGS Sample Preparation Market Attractiveness Analysis, by Product, 2021–2030
Figure 08: Global NGS Sample Preparation Market Value (US$ Mn), by Instruments, 2018–2030
Figure 09: Global NGS Sample Preparation Market Value (US$ Mn), by Extraction kits, Reagents, and Consumables, 2018–2030
Figure 10: Global NGS Sample Preparation Market Value Share Analysis, by Application, 2020 and 2030
Figure 11: Global NGS Sample Preparation Market Attractiveness Analysis, by Application, 2021–2030
Figure 12: Global NGS Sample Preparation Market Value (US$ Mn), by Drug and Biomarker Discovery, 2018–2030
Figure 13: Global NGS Sample Preparation Market Value (US$ Mn), by Diagnostics, 2018–2030
Figure 14: Global NGS Sample Preparation Market Value (US$ Mn), by Precision Medicine, 2018–2030
Figure 15: Global NGS Sample Preparation Market Value (US$ Mn), by Others, 2018–2030
Figure 16: Global NGS Sample Preparation Market Value Share Analysis, by End-user, 2020 and 2030
Figure 17: Global NGS Sample Preparation Market Attractiveness Analysis, by End-user, 2021–2030
Figure 18: Global NGS Sample Preparation Market Value (US$ Mn), by Hospitals & Clinical Diagnostic Centers, 2018-2030
Figure 19: Global NGS Sample Preparation Market Value (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2018–2030
Figure 20: Global NGS Sample Preparation Market Value (US$ Mn), by Academic & Research Institutes, 2018–2030
Figure 21: Global NGS Sample Preparation Market Value (US$ Mn), by Others, 2018–2030
Figure 22: Global NGS Sample Preparation Market Value Share Analysis, by Region, 2020 and 2030
Figure 23: Global NGS Sample Preparation Market Attractiveness Analysis, by Region, 2021–2030
Figure 24: North America NGS Sample Preparation Market Value (US$ Mn) Forecast, 2018–2030
Figure 25: North America NGS Sample Preparation Market Value Share Analysis, by Country, 2020 and 2030
Figure 26: North America NGS Sample Preparation Market Attractiveness Analysis, by Country, 2021–2030
Figure 27: North America NGS Sample Preparation Market Value Share Analysis, by Product, 2020 and 2030
Figure 28: North America NGS Sample Preparation Market Attractiveness Analysis, by Product, 2021–2030
Figure 29: North America NGS Sample Preparation Market Value Share Analysis, by Application, 2020 and 2030
Figure 30: North America NGS Sample Preparation Market Attractiveness Analysis, by Application, 2021–2030
Figure 31: North America NGS Sample Preparation Market Value Share Analysis, by End-user, 2020 and 2030
Figure 32: North America NGS Sample Preparation Market Attractiveness Analysis, by End-user, 2021–2030
Figure 33: Europe NGS Sample Preparation Market Value (US$ Mn) Forecast, 2018–2030
Figure 34: Europe NGS Sample Preparation Market Value Share Analysis, by Country/Sub-region, 2020 and 2030
Figure 35: Europe NGS Sample Preparation Market Attractiveness Analysis, by Country/Sub-region, 2021–2030
Figure 36: Europe NGS Sample Preparation Market Value Share Analysis, by Product, 2020 and 2030
Figure 37: Europe NGS Sample Preparation Market Attractiveness Analysis, by Product, 2021–2030
Figure 38: Europe NGS Sample Preparation Market Value Share Analysis, by Application, 2020 and 2030
Figure 39: Europe NGS Sample Preparation Market Attractiveness Analysis, by Application, 2021–2030
Figure 40: Europe NGS Sample Preparation Market Value Share Analysis, by End-user, 2020 and 2030
Figure 41: Europe NGS Sample Preparation Market Attractiveness Analysis, by End-user, 2021–2030
Figure 42: Asia Pacific NGS Sample Preparation Market Value (US$ Mn) Forecast, 2018–2030
Figure 43: Asia Pacific NGS Sample Preparation Market Value Share Analysis, by Country/Sub-region, 2020 and 2030
Figure 44: Asia Pacific NGS Sample Preparation Market Attractiveness Analysis, by Country/Sub-region, 2021–2030
Figure 45: Asia Pacific NGS Sample Preparation Market Value Share Analysis, by Product, 2020 and 2030
Figure 46: Asia Pacific NGS Sample Preparation Market Attractiveness Analysis, by Product, 2021–2030
Figure 47: Asia Pacific NGS Sample Preparation Market Value Share Analysis, by Application, 2020 and 2030
Figure 48: Asia Pacific NGS Sample Preparation Market Attractiveness Analysis, by Application, 2021–2030
Figure 49: Asia Pacific NGS Sample Preparation Market Value Share Analysis, by End-user, 2020 and 2030
Figure 50: Asia Pacific NGS Sample Preparation Market Attractiveness Analysis, by End-user, 2021–2030
Figure 51: Latin America NGS Sample Preparation Market Value (US$ Mn) Forecast, 2018–2030
Figure 52: Latin America NGS Sample Preparation Market Value Share Analysis, by Country/Sub-region, 2020 and 2030
Figure 53: Latin America NGS Sample Preparation Market Attractiveness Analysis, by Country/Sub-region, 2021–2030
Figure 54: Latin America NGS Sample Preparation Market Value Share Analysis, by Product, 2020 and 2030
Figure 55: Latin America NGS Sample Preparation Market Attractiveness Analysis, by Product, 2021–2030
Figure 56: Latin America NGS Sample Preparation Market Value Share Analysis, by Application, 2020 and 2030
Figure 57: Latin America NGS Sample Preparation Market Attractiveness Analysis, by Application, 2021–2030
Figure 58: Latin America NGS Sample Preparation Market Value Share Analysis, by End-user, 2020 and 2030
Figure 59: Latin America NGS Sample Preparation Market Attractiveness Analysis, by End-user, 2021–2030
Figure 60: Middle East & Africa NGS Sample Preparation Market Value (US$ Mn) Forecast, 2018–2030
Figure 61: Middle East & Africa NGS Sample Preparation Market Value Share Analysis, by Country/Sub-region, 2020 and 2030
Figure 62: Middle East & Africa NGS Sample Preparation Market Attractiveness Analysis, by Country/Sub-region, 2021–2030
Figure 63: Middle East & Africa NGS Sample Preparation Market Value Share Analysis, by Product, 2020 and 2030
Figure 64: Middle East & Africa NGS Sample Preparation Market Attractiveness Analysis, by Product, 2021–2030
Figure 65: Middle East & Africa NGS Sample Preparation Market Value Share Analysis, by Application, 2020 and 2030
Figure 66: Middle East & Africa NGS Sample Preparation Market Attractiveness Analysis, by Application, 2021–2030
Figure 67: Middle East & Africa NGS Sample Preparation Market Value Share Analysis, by End-user, 2020 and 2030
Figure 68: Middle East & Africa NGS Sample Preparation Market Attractiveness Analysis, by End-user, 2021–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
NGS Sample Preparation Market Trends, 2020-2030
